- Joined
- Dec 19, 2010
- Messages
- 10,255
- Reaction score
- 13,584
Sharp car.Just got a new Tesla S
Sharp car.Just got a new Tesla S
Agreed holding it for the long term. I consider it gambling. I might lose all or most of it, but the potential to make 10X on the original amount is huge if Lucid is a success.
Just got a new Tesla S (with the wacky steering wheel) but I definitely would have gotten Lucid if it was available as I think the design and branding are better.
This concern is a big reason why Lucid may break out from the rest of the pack. Their range off a single charge is better than any other EV -- up to 520 miles per the EPA. And with their tech it takes 20 mins of charging to yield 300mi of range.
Thought you said something about potentially losing your job
I doubt competition in the EV market is going to be a problem. Everyone and their grandmother is trying to manufacture EVs now. Ford already has a huge waitlist for their F150 lightning.LCID was up 10% today, but it generally has big ups and downs. I've seen the range figures, but they have yet to actually put the car into production. QC on the battery cells might limit real world range. We will see how they do. I'm hopeful because we need a good EV competitor.
I hope you are right. Tesla's only choice is to raise the bar on quality and interior fit/finish or they will be destroyed. Their main is technology, and their EV powertrain is unbeatable at the moment. I considered the Taycan as well, but for $105,000 base price it didn't make much sense. In typical Porsche fashion they make you buy "packages" just to get a few features you want, and reasonably optioned was over $120K. Likewise the new Mercedes EQS, which should be competition starts at over 100K for a relatively low-performing, single motor version.I doubt competition in the EV market is going to be a problem. Everyone and their grandmother is trying to manufacture EVs now. Ford already has a huge waitlist for their F150 lightning.
The bigger companies like Toyota or Honda will likely have the added advantage of not having the production shortages that Tesla has had forever,
Chip shortage not withstanding.
Since Tesla hasn’t exactly cornered the market on EVs like say apple did with the smartphone, they’re going to get smoked by the competition.
LCID was up 10% today, but it generally has big ups and downs. I've seen the range figures, but they have yet to actually put the car into production. QC on the battery cells might limit real world range. We will see how they do. I'm hopeful because we need a good EV competitor.
Too much going on today to see it dipped below 24.5, might have bought more then. Suspect a pop coming next week.
Theta gang!Re: LCID, if anyone is into writing puts as a means to acquire stock (which is a very good way)...the Oct 15 21.00 put has a bid of 0.71.
What that means is if you sell one contract, you get $71 up front for you to keep. No matter what. You never get it back. If LCID ends up < 21.00 by October 15, you are required to buy 100 shares of LCID at 21.00 (meaning you have to have or keep about $2100 collateral in your account). That is a legal obligation you can't get out of it.
But if LCID ends >= 21.00, then you keep the $71.00. What this means is that if the option expires worthless, you have set aside $2100 to make $71 in about 3 weeks time. That represents a 3.4% return on your investment or capital. (0.71 / 21.00 = 0.034). That's pretty darn good. If you do that three times a year, you will have made about 10% return. That more or less beats the S&P return.
Incidentally, Black-Sholes Model theory suggests that the probability of assignment (meaning you have to buy 100 shares) of the above put option is 18%. 18% of the time you are buying stock, 82% of the time you are not. 100% of the time you get to keep $71. It's remarkable how closely theory parallels real life statistics.
Theta gang!
By the way, you aren't necessarily legally obligated to buy shares with a put, as long as you buy to close before the expiration date.
If I'm making any serious money off of a specific option (not, say, $10 for a Ford weekly), I'll normally close out at $5. First, I can always turn around and resell a covered call at a higher strike price, second I've seen some of my calls go from worthless on Wednesday to closing in the money on Friday.Thetagang indeed!
And you are right...you can definitely close your position before expiration and make a fraction (50%, 75%, etc) of your initial credit. But since this is an MD forum and not an investing forum, I chose not to mention that.
If I'm making any serious money off of a specific option (not, say, $10 for a Ford weekly), I'll normally close out at $5. First, I can always turn around and resell a covered call at a higher strike price, second I've seen some of my calls go from worthless on Wednesday to closing in the money on Friday.
Now that people have been threatened with sanctions by their medical board for considering Ivermectin, how much bias will that introduce in the current research ongoing on the use of Ivermectin in COVID?Anyone still curious about ivermectin?
Here in SC MUSC has started an ivermectin clinical trial. If anyone asks about it I give them the handout for the clinical trial and let them go from there.Ivermectin --> Boosters --> Car analogy --> Lucid --> Stock options.
Anyone still curious about ivermectin? Or has this thread run its course?
No. It kills parasites by acting on invertebrate nerve and muscle cell membrane permeability. SARS-CoV-2 is a virus. Ivermectin as a treatment for COVID-19 lost the basic trial of credibility based upon its mechanism of action.Is it even possible, for ivermectin to get a "fair trial" at this point, so to speak?
I hope you are right. Tesla's only choice is to raise the bar on quality and interior fit/finish or they will be destroyed. Their main is technology, and their EV powertrain is unbeatable at the moment. I considered the Taycan as well, but for $105,000 base price it didn't make much sense. In typical Porsche fashion they make you buy "packages" just to get a few features you want, and reasonably optioned was over $120K. Likewise the new Mercedes EQS, which should be competition starts at over 100K for a relatively low-performing, single motor version.
As we all know, any study can be picked apart in some way or another. But, if its a reasonably well designed study that shows benefit I would hope it gets published without too much trouble. I would say that I also hope they would be much more thorough and deliberate than usual for something like this to minimize that sort of thing.Now that people have been threatened with sanctions by their medical board for considering Ivermectin, how much bias will that introduce in the current research ongoing on the use of Ivermectin in COVID?
Let's say you're running a trial on ivermectin. It's a randomized, double blinded, placebo controlled trial. You've heard that you're a quack if you prescribe ivermectin, talk about it, espouse it or even have an open mind about it. Everyone that think it works, might work or could work possibly maybe in a million years, is a pariah. You're expecting your trial to be negative, because of all the chatter.
Then, your results come in, and they're strongly positive. What do you do? Do you publish? Do you feel free to publish? Do you start questioning the results, go back and "take another look," perhaps considering ways to "look differently at the data?" Do you start wondering about the consequences of publishing a positive study? Will you be looked at as a quack? Will your future work be questioned?
Is it even possible, for ivermectin to get a "fair trial" at this point, so to speak?
Getting published is one thing. People accepting a new finding, even if accurate and true, would be entirely something else.As we all know, any study can be picked apart in some way or another. But, if its a reasonably well designed study that shows benefit I would hope it gets published without too much trouble. I would say that I also hope they would be much more thorough and deliberate than usual for something like this to minimize that sort of thing.
Maybe?Getting published is one thing. People accepting it, even if accurate and true, would be entirely something else.
You really think the “smart people” would be so quick to admit they were wrong, change course and start recommending a new standard of care?
No frickin’ way, if even two or a hundred studies are positive, are the “smart people” going to reverse their threats of sanctioning people, and all of a sudden admit they were dead wrong. No frickin’ way. They’ll hum, they’ll haw, they say, “Well, but uh…we..uh…hrrum…hrrum…have other better treatments now, such as …. and ….blah blah, such that we don’t have to prescribe HORSE MEDICINE, to people after all.”Maybe?
I'm pretty anti-ivermectin at the moment, but if a halfway decent trial comes up saying it helps I'll likely change my practice. Looks like lots of different places are looking into this. If several reputable places all have positive results, that should count for something.
Yeah, lol. That reminds me. Recently, my wife was telling me about a mutual acquaintance of ours whose kid was recently diagnosed with "chronic Lyme" and who was thinking about taking her to Mexico for some "experimental treatments" so cutting edge, you "can't get them in America, yet." Lol.The last few posts from @Birdstrike just reminded me of something from over 40 years ago. Laetrile, anybody? Ask Steve McQueen how that turned out.
Narc!I've tested ABEM's professionalism reporting tool by sending in an ED doc operating a quick-buck telemedicine service giving on-demand ivermectin + fluvoxamine prescriptions.
I highly doubt there's any teeth to it.
It depends what claims he's making. If he's prescribing a medication and claiming it does something it doesn't then that would be fraud. Writing to the State Medical Board would probably get more done.I've tested ABEM's professionalism reporting tool by sending in an ED doc operating a quick-buck telemedicine service giving on-demand ivermectin + fluvoxamine prescriptions.
I highly doubt there's any teeth to it.
I'm all for it. Natural Selection at work.this has taken an interesting turn…
can you imagine how much nebulized hydrogen peroxide would burn the lungs?
'Vigilante treatments': Anti-vaccine groups push people to leave ICUs
As the anti-vaccine movement escalates its rhetoric, doctors warn that they're dealing with the fallout: "They’re starting to target people, the messengers — nurses and doctors."www.nbcnews.com
I'm all for it. Natural Selection at work.
I think nebulized hydrogen peroxide would definitely kill COVID Particles in the lungs....so there's that.i’m just imaging some poor grandpa going along with what the kids want not really realizing what’s going on and getting taken out of the hospital for “hospice care” only to get subjected to this ivermectin and nebulized hydrogen peroxide “protocol”. jesus.
I think nebulized hydrogen peroxide would definitely kill COVID Particles in the lungs....so there's that.
This i agree With you… if they don’t want any of the actual treatment… or supportive care… that is available at the hospital…give that icu bed to someone who deserves it.I'm all for it. Natural Selection at work.
It's hard when we have welfare programs and food stamps that keep people going who would otherwise be unable to support themselves.
What is this nonsense?
What kind of nonsense is this then...Trial of outpatient drugs for COVID-19 opens to all South Carolinians
A clinical trial is enrolling people with mild COVID-19 to see if any of three existing drugs work against the disease.web.musc.edu
It was a rhetorical question.It's all f'ing nonsense. I'll prescribe ivermectin once all the studies are back and a bunch of people around a round table, who are 10 times smarter than me, endorse it. Until then ivermectin is junk and best used on large 4-legged animals with parasitic infections.
Nonsense that is.It was a rhetorical question.
So that isn't as clear as it should be (thanks for making me defend MUSC).What kind of nonsense is this then...
"People interested in the trial will have the option to choose which study arm they would like to be a part of."
WTF kind of "science" is that?
Slightly less stupid.So that isn't as clear as it should be (thanks for making me defend MUSC).
The trial is studying 3 different drugs. Patients can choose which drug arm they want to be in. They are then randomized to either control or treatment arm for that drug.
I can't wait to see how few people opt for the flovent or fluvoxamine arm.Slightly less stupid.
Yeah, especially as the evidence for those two is much stronger than ivermectin...I can't wait to see how few people opt for the flovent or fluvoxamine arm.
I can't wait to see how few people opt for the flovent or fluvoxamine arm.
Obvious breaches get immediate action.Last edited by a moderator: A moment ago
Nice, real nice. Admin knows how much I just love anonymous moderation.